AVTX- Avalo Therapeutics, Inc.

Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.

Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Neil Garry Arthur	190.3K	-	-
Other	Boyd Taylor	95.0K	-	-
Other	Doyle Mittie	51.8K	$1.04M	-
CFO	Sullivan Christopher Ryan	39.9K	$651.7K	-
Other	Riley Jennifer	37.0K	$725.6K	-

Buys and sells only

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 11, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	56,329	$2.53	$142,516.39	+4.7%	-88.3%	-98.0%
Feb 7, 2023	Armistice Capital, LLC56	10% Owner	Buy	450,000	$0.00	-	+11.3%	-23.7%	-99.5%
Dec 9, 2022	Neil Garry Arthur	CEO And Chairman Of The Board	Buy	2,083	$4.42	$9,206.86	+29.2%	-53.5%	-99.0%
Mar 14, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	226,000	$0.67	$151,946.00	+0.5%	-31.3%	-67.4%
Mar 7, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	510,000	$0.67	$344,132.50	+1.1%	-48.2%	-69.2%
Feb 25, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	140,000	$0.80	$111,806.00	+0.3%	-59.2%	-69.5%
Feb 22, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	288,000	$0.80	$231,563.50	+0.6%	-60.0%	-68.5%
Jan 20, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	312,000	$0.88	$274,486.28	+0.7%	-30.1%	-50.1%
Jan 14, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	455,000	$1.00	$452,767.93	+1.0%	-40.1%	-59.5%
Jan 11, 2022	Armistice Capital, LLC56	Director, 10% Owner	Buy	645,000	$1.00	$642,931.32	+1.4%	-33.5%	-56.4%